| Product Name | MF | CAS | Details |
|---|
| Anti-IL-2Ra / CD25 Reference Antibody (basiliximab) | Details |
| Anti-IL-2Ra / CD25 Reference Antibody (camidanlumAb) | Details |
| Anti-IL-2Ra / CD25 Reference Antibody (daclizumab) | Details |
| Anti-IL-2Rb / CD122 Reference Antibody (Singapore ASTR patent anti-IL-2R beta / IL-2R gamma ) | Details |
| Anti-IL-31Ra Reference Antibody (nemolizumab) | Details |
| Anti-IL-33 Reference Antibody (etokimab) | Details |
| Anti-IL-33 Reference Antibody (itepekimab) | Details |
| Anti-IL-33 Reference Antibody (torudokimab) | Details |
| Anti-IL-33 Reference Antibody (tozorakimab) | Details |
| Anti-IL-3Ra / CD123 Reference Antibody (SNG-CD123A) | Details |
| Anti-IL-3Ra / CD123 Reference Antibody (talacotuzumab) | Details |
| Anti-IL-4 Reference Antibody (pascolizumab) | Details |
| Anti-IL-4Ra / CD124 Reference Antibody (dupilumab) | Details |
| Anti-IL-4Ra / CD124 Reference Antibody (MEDI2045) | Details |
| Anti-IL-5 Reference Antibody (Abgenix anti-IL-5) | Details |
| Anti-IL-5 Reference Antibody (depemokimab) | Details |
| Anti-IL-5 Reference Antibody (mepolizumab) | Details |
| Anti-IL-5Ra/ CD125 Reference Antibody (benralizumab) | Details |
| Anti-IL-6 / IFNb2 Reference Antibody (Chugai SK2) | Details |
| Anti-IL-6 / IFNb2 Reference Antibody (clazakizumab) | Details |
| Anti-IL-6 / IFNb2 Reference Antibody (CSTRI patent anti-IL-6) | Details |
| Anti-IL-6 / IFNb2 Reference Antibody (elsilimomab) | Details |
| Anti-IL-6 / IFNb2 Reference Antibody (Medarex patent anti-IL-6) | Details |
| Anti-IL-6 / IFNb2 Reference Antibody (MEDI 5117) | Details |
| Anti-IL-13 Reference Antibody (M1295) | Details |
| Anti-IL-13 Reference Antibody (tralokinumab) | Details |
| Anti-IL-13Ra1 / CD213a1 Reference Antibody (MK-6105) | Details |
| Anti-IL-13Ra2 / CD213a2 Reference Antibody (Wake Forest U. patent anti-IL-13RA2) | Details |
| Anti-IL-15 Reference Antibody (DISC0280) | Details |
| Anti-IL-15 Reference Antibody (ordesekimab) | Details |
| Anti-IL-17c Reference Antibody (MOR106) | Details |
| Anti-IL-17Ra / CD217 Reference Antibody (brodalumab) | Details |
| Anti-IL-18 Reference Antibody (ABT-325) | Details |
| Anti-IL-18 Reference Antibody (GSK 1070806) | Details |
| Anti-IL-1a Reference Antibody (bermekimab) | Details |
| Anti-IL-1b Reference Antibody (canakinumab) | Details |
| Anti-IL-1b Reference Antibody (CDP484) | Details |
| Anti-IL-1b Reference Antibody (gevokizumab) | Details |
| Anti-IL-1R1 / CD121a Reference Antibody (AMG 108) | Details |
| Anti-IL-1RAP / IL-1R3 Reference Antibody (nidanilimab) | Details |
| Anti-IL-1RL1 / ST2 / IL-33R Reference Antibody (astegolimab) | Details |
| Anti-IL-1RL1 / ST2 / IL-33R Reference Antibody (melrilimab) | Details |
| Anti-IL-1RL2 / IL-36R Reference Antibody (imsidolimab) | Details |
| Anti-IL-1RL2 / IL-36R Reference Antibody (spesolimab) | Details |
| Anti-IL-20 Reference Antibody (Cheng Kung U. patent anti-IL-20) | Details |
| Anti-IL-20 Reference Antibody (fletikumab) | Details |
| Anti-IL-20Ra Reference Antibody (Cheng Kung U. patent anti-IL-20R1) | Details |
| Anti-IL-21 Reference Antibody (avizakimab) | Details |
| Anti-IL-21 Reference Antibody (Lilly patent anti-IL-21) | Details |
| Anti-IL-22 Reference Antibody (fezakinumab) | Details |
| Anti-IL-22Ra Reference Antibody (ARGX-112) | Details |
| Anti-IL-23 Reference Antibody (brazikumab) | Details |
| Anti-IL-23 Reference Antibody (guselkumab) | Details |
| Anti-IL-23 Reference Antibody (LY2525623) | Details |
| Anti-IL-23 Reference Antibody (mirikizumab) | Details |
| Anti-IL-23a Reference Antibody (risankizumab) | Details |
| Anti-IL-23a Reference Antibody (tildrakizumab) | Details |
| Anti-IL-25 Reference Antibody (Centocor patent anti-IL-25) | Details |
| Anti-IL-6 / IFNb2 Reference Antibody (Merck patent anti-IL-6) | Details |
| Anti-IL-6 / IFNb2 Reference Antibody (olokizumab) | Details |
| Anti-IL-6 / IFNb2 Reference Antibody (siltuximab) | Details |
| Anti-IL-6 / IFNb2 Reference Antibody (sirukumab) | Details |
| Anti-IL-6 / IFNb2 Reference Antibody (ziltivekimab) | Details |
| Anti-IL-6Ra / CD126 Reference Antibody (APX007) | Details |
| Anti-IL-6Ra / CD126 Reference Antibody (levilimab) | Details |
| Anti-IL-6Ra / CD126 Reference Antibody (sapelizumab) | Details |
| Anti-IL-6Ra / CD126 Reference Antibody (sarilumab) | Details |
| Anti-IL-6Ra / CD126 Reference Antibody (tocilizumab) | Details |
| Anti-IL-6Ra / CD126 Reference Antibody (vobarilizumab) | Details |
| Anti-IL-7Ra / CD127 Reference Antibody (lusvertikimab) | Details |
| Anti-IL-7Ra / CD127 Reference Antibody (PF-06342674) | Details |
| Anti-IL-9 Reference Antibody (enokizumab) | Details |
| Anti-ILDR2 Reference Antibody (bapotulimab) | Details |
| Anti-INHBA / Activin A Reference Antibody (garetosmab) | Details |
| Anti-INHBB / Activin B Reference Antibody (Oxford Brookes U. patent anti-Activin Beta-B) | Details |
| Anti-Integrin a11 / ITAG11 Reference Antibody (Scripps patent anti-CD11a) | Details |
| Anti-Integrin a2b1 (ITGA2 & ITGB1) Reference Antibody (vatelizumab) | Details |
| Anti-Integrin a2b3 (ITGA2 & ITGB3) Reference Antibody (tadocizumab) | Details |
| Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody (abrilumab) | Details |
| Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody (etrolizumab) | Details |
| Anti-Integrin a4b7 (ITGA4 & ITGB7) Reference Antibody (vedolizumab) | Details |
| Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody (BMS patent anti-Integrin α5β1) | Details |
| Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody (volociximab) | Details |
| Anti-Integrin aL / ITGAL / CD11a Reference Antibody (efalizumab) | Details |
| Anti-Integrin aV / ITGAV / CD51 Reference Antibody (abituzumab) | Details |
| Anti-Integrin aV / ITGAV / CD51 Reference Antibody (intetumumab) | Details |
| Anti-Integrin aVb3 (ITGAV & ITGB3) Reference Antibody (etaracizumab) | Details |
| Anti-Integrin aVb6 (ITGAV & ITGB6) Reference Antibody (STX-100) | Details |
| Anti-Integrin b1 / ITGB1 / CD29 Reference Antibody (OS2966) | Details |
| Anti-Integrin b2 / ITGB2 / CD18 Reference Antibody (erlizumab) | Details |
| Anti-Integrin b7 / ITGB7 Reference Antibody (Genentech patent anti-Integrin β7) | Details |
| Anti-KAAG1 Reference Antibody (ADCT-901) | Details |
| Anti-KID3 Reference Antibody (Macrogenics patent anti-KID3) | Details |
| Anti-KIR Reference Antibody (lirilumab) | Details |
| Anti-KIR2DL1 / CD158a Reference Antibody (Innate patent anti-KIR2DL) | Details |
| Anti-KIR3DL2 / CD158k Reference Antibody (lacutamab) | Details |
| Anti-KLK2 / Kallikrein 2 Reference Antibody (JNJ-69086420) | Details |
| Anti-KLK5 / Kallikrein 5 Reference Antibody (Genentech patent anti-KLK5) | Details |
| Anti-Klotho Beta Reference Antibody (NGM313) | Details |
| Anti-Klotho Beta Reference Antibody (RG7992) | Details |
| Product Total： Product Page： | ||||
| 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 | ||||